ClinConnect ClinConnect Logo
Search / Trial NCT06602076

Developing an SGM Smoking Cessation Intervention With Community Partners

Launched by UNIVERSITY OF OKLAHOMA · Sep 16, 2024

Trial Information

Current as of July 25, 2025

Not yet recruiting

Keywords

Lgbt Tobacco Use Smoking Cessation Sexual And Gender Minorities

ClinConnect Summary

This clinical trial, called "Developing an SGM Smoking Cessation Intervention With Community Partners," aims to help sexual and gender minority (SGM) individuals quit smoking, especially those living in areas where they face discrimination and stigma. Researchers believe that when SGM individuals engage in volunteer activities that benefit their communities, they may gain social support and develop a stronger sense of pride in their identity, which can help them quit smoking. The trial will involve participants receiving standard smoking cessation support while also participating in community service activities that empower SGM people.

To participate, individuals must be at least 18 years old, identify as part of the SGM community, currently smoke cigarettes, and live in a high-stigma area in the U.S. They should also be willing to quit smoking within 30 days of joining the study and have access to the internet and a smartphone. The trial is still in the planning stages and has not started recruiting participants yet. This important research aims to create a smoking cessation program that is tailored to the unique experiences of SGM individuals, ultimately helping them lead healthier lives.

Gender

ALL

Eligibility criteria

  • Inclusion/exclusion criteria (All Aims):
  • Sexual and/or gender minority (SGM)-identified
  • Adults (i.e., ≥ 18 years old)
  • Currently smoking cigarettes
  • Living in a high stigma environment in the U.S.
  • Able to read English at \> 6th-grade level
  • Individuals with serious psychological distress (i.e., score of 13 ≥ 18 on the Kessler PD Scale-6 19) will be excluded from all Aims because of likelihood of functional impairments that substantially interfere with one or more major life activities.
  • Aim 3 (Pilot RCT) inclusion criteria will be:
  • (1) ≥ 18 years old
  • (2) sexual and/or gender minority-identified (see definition above)
  • (3) living in Oklahoma or one of the 8 counties in San Joaquin Valley, California (verified by address)
  • (4) a current cigarette smoker (see definition above)
  • (5) willing to quit smoking within 30 days of enrollment (see definition above)
  • (6) own a smartphone
  • (7) ability to read English at \> 6th-grade level (see definition above)
  • have no NRT contraindications
  • (8) ≥ weekly internet access
  • (9) willing and able to participate in SGM-serving volunteer activities.
  • Aim 3 (Pilot RCT) exclusion criteria: Individuals will be excluded if currently using other smoking cessation treatments.
  • Sexual minority identity will be indicated by selecting any non-heterosexual response option(s) from: Heterosexual (Straight); Gay or Lesbian; Bisexual; Something else (please state)." Participants will indicate the sex assigned on their birth certificate (i.e., natal sex). Gender minority identity will be indicated by "Trans male/Trans man;" "Trans female/Trans woman;" "Gender queer/Gender non-conforming;" "Different identity (please state)" or a binary identity (male or female) non-concordant with natal sex. Current cigarette smoking will be indicated by ≥100 lifetime cigarettes and currently smoking cigarettes "every day" or "some days". High SGM stigma states are defined as the 22 states wherein ˂60% of the population 'thinks that homosexuality should be accepted'.21 High SGM stigma municipalities are defined as one of the 246 U.S. municipalities (out of the 496 scored from all U.S. states) that scored below the median (71) on the HRC Municipal Equality Index. Willingness to quit smoking will be assessed with a single item: "Are you willing to quit smoking cigarettes within 30 days after enrolling in this study? (yes/no)". To be classified as 'ready to quit smoking,' participants will report readiness to quit in the next 30 days and at least 1 past-year quit attempt (i.e., in the "Preparation" stage of change).
  • An equal number of female and male participants (i.e., natal sex) will be recruited so as to examine sex as a biological factor. Recruitment targets will aim to reflect the racial/ethnic composition of the populations from which the samples are drawn.

About University Of Oklahoma

The University of Oklahoma, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials and research initiatives. With a robust network of interdisciplinary experts and state-of-the-art facilities, the university fosters an environment that promotes scientific discovery and the development of new treatments. Its commitment to patient-centered research ensures that clinical trials not only adhere to the highest ethical standards but also aim to address pressing health challenges. By collaborating with various stakeholders, including industry partners and healthcare providers, the University of Oklahoma seeks to translate research findings into tangible benefits for communities, ultimately enhancing the quality of care and improving health outcomes.

Locations

Patients applied

0 patients applied

Trial Officials

Julia M McQuoid, PhD

Principal Investigator

Associate Professor

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported